These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31021945)

  • 1. Barriers to Reproductive Healthcare for Women With Opioid Use Disorder.
    Smith C; Morse E; Busby S
    J Perinat Neonatal Nurs; 2019; 33(2):E3-E11. PubMed ID: 31021945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
    Matusiewicz AK; Melbostad HS; Heil SH
    Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont.
    Rey CN; Badger GJ; Melbostad HS; Wachtel D; Sigmon SC; MacAfee LK; Dougherty AK; Heil SH
    Contraception; 2020 May; 101(5):333-337. PubMed ID: 32014521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.
    Stancil SL; Miller MK; Duello A; Finocchario-Kessler S; Goggin K; Winograd RP; Hurley EA
    Harm Reduct J; 2021 Aug; 18(1):83. PubMed ID: 34348734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
    Luo Z; Gao L; Anguzu R; Zhao J
    Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projections and opinions from 100 experts in long-acting reversible contraception.
    Foster DG; Barar R; Gould H; Gomez I; Nguyen D; Biggs MA
    Contraception; 2015 Dec; 92(6):543-52. PubMed ID: 26515195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
    Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
    Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Practice Registered Nurses and Long-Acting Reversible Contraception.
    Kelly PJ; Cheng AL; Carlson K; Witt J
    J Midwifery Womens Health; 2017 Mar; 62(2):190-195. PubMed ID: 28340500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.
    Garrett CC; Keogh LA; Kavanagh A; Tomnay J; Hocking JS
    BMC Womens Health; 2015 Sep; 15():72. PubMed ID: 26359250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge and Acceptability of Long-Acting Reversible Contraception Among Adolescent Women Receiving School-Based Primary Care Services.
    Hoopes AJ; Ahrens KR; Gilmore K; Cady J; Haaland WL; Amies Oelschlager AM; Prager S
    J Prim Care Community Health; 2016 Jul; 7(3):165-70. PubMed ID: 27067583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative analysis of long-acting reversible contraception.
    Sundstrom B; Baker-Whitcomb A; DeMaria AL
    Matern Child Health J; 2015 Jul; 19(7):1507-14. PubMed ID: 25424456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes toward long-acting reversible contraception among young women seeking abortion.
    Rose SB; Cooper AJ; Baker NK; Lawton B
    J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive Health Knowledge, Attitudes, and Behaviors Among Women Enrolled in Medication-Assisted Treatment for Opioid Use Disorder.
    Meschke LL; McNeely C; Brown KC; Prather JM
    J Womens Health (Larchmt); 2018 Oct; 27(10):1215-1224. PubMed ID: 29969340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
    Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
    Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to Health Care Providers' Provision of Long-Acting Reversible Contraception to Adolescent and Nulliparous Young Women.
    Hopkins B
    Nurs Womens Health; 2017; 21(2):122-128. PubMed ID: 28388997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
    Harney C; Dude A; Haider S
    Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
    ; Vricella LK; Gawron LM; Louis JM
    Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.